New Jersey: A Leader in Innovative Best Practices to Reduce Opioid Use

New Jersey: A Leader in Innovative Best Practices to Reduce Opioid Use

COMPILED BY JOHN JOSEPH PARKER, CONTRIBUTING EDITOR

AS PART OF THE MURPHY administration’s strategic efforts to combat the opioid crisis, the New Jersey Department of Health and New Jersey Department of Human Services (DHS) have teamed up to launch the Opioid Reduction Options (ORO) program aimed at reducing opioid pre­scribing to treat chronic pain in hospital emergency departments.

The program will provide training and education to health systems on other pain relief options in place of opioids. The initiative builds on efforts by the Office of the Attorney General to regulate opioid prescribing, educate prescribers about the risks associated with opioids and target enforcement efforts against reckless and criminal over-prescribers.

“New Jersey has made some progress in reducing opioid prescribing, but we know that well over half of substance use disorders still start with a prescrip­tion,” explains New Jersey Health Commissioner Dr. Shereef Elnahal. “This project aims to prevent an addic­tion that starts with a visit to the emer­gency department—an important piece of the Murphy Administration’s preven­tion agenda in fighting the opioid epidemic.”

DHS Commissioner Carole Johnson adds, “We are pleased to join with the Department of Health and New Jersey’s hospital leaders in advancing best practices to combat the opioid epi­demic. It is important to our state strate­gy that we make sure medical providers are aware of the options and we look forward to funding this initiative throughout the state.”

Nationally, emergency departments prescribe opioids at a rate of about 17 percent. New Jersey is home to best practices that reduce opioid prescrib­ing—St. Joseph’s Health reduced opioid prescribing down to 2 percent. The hos­pital has been recognized nationally.

“St. Joseph’s Health launched The Alternatives to Opioids program (ALTO®) in 2016 to offer a real solution to a rap­idly growing opioid epidemic,” says Mark Rosenberg, D.O., chairman of Emergency Medicine and chief innova­tion officer, St. Joseph’s Health. “Since then, we have witnessed tremendous success using the ALTO® protocols—reducing opioid prescriptions by more than 82 percent in the St. Joseph’s Emergency Department. We are stop­ping addiction before it starts.”

By providing training and curriculum to hospital emergency department staff, ORO will promote best practices, such as those used at St. Joseph’s Health as well as those used at other health systems, with the goal to ulti­mately to reduce overall opioid pre-scribing in New Jersey’s emergency rooms to 12 percent or less.

“New Jersey continues to be a leader in innovative practices to stem the tragedy of opioid abuse,” said Cathleen Bennett, New Jersey Hospital Association (NJHA) president and CEO. “The NJHA applauds the state for its leader­ship in developing the ORO program, and we’re honored to be partners with St. Joseph’s Health in bringing new opportunities for hospitals and health systems to meet patients’ needs without putting them at greater risk for opioid dependency.”

The Department of Health has part­nered with the NJHA to implement this program. The NJHA will be consult­ing closely with St. Joseph’s Health to develop the training and curriculum and to develop a learning environment where other health system leaders in this space may share their evidence-based practices.

View all featured articles